|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
59,420,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
551,455 |
642,217 |
Total Buy Value |
$0 |
$0 |
$778,895 |
$1,265,385 |
Total People Bought |
0 |
0 |
4 |
4 |
Total Buy Transactions |
0 |
0 |
7 |
12 |
Total Shares Sold |
6,719 |
6,719 |
14,725 |
34,618 |
Total Sell Value |
$18,410 |
$18,410 |
$41,694 |
$143,993 |
Total People Sold |
1 |
1 |
2 |
2 |
Total Sell Transactions |
1 |
1 |
4 |
11 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2023-01-10 |
4 |
AS |
$4.57 |
$8,523 |
D/D |
(1,865) |
0 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2023-01-09 |
4 |
AS |
$5.11 |
$9,530 |
D/D |
(1,865) |
95,819 |
|
- |
|
Cooper Ronald Harold Wilfred |
|
|
2023-01-05 |
4 |
A |
$5.12 |
$48,640 |
D/D |
9,500 |
9,500 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$6,794 |
D/D |
(1,211) |
2,914 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
4,125 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$12,252 |
D/D |
(2,184) |
15,763 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
17,947 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$12,252 |
D/D |
(2,184) |
213,917 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
216,101 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$12,252 |
D/D |
(2,184) |
344,801 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
346,985 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$6,794 |
D/D |
(1,211) |
95,819 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
97,030 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2022-10-15 |
4 |
D |
$5.61 |
$58,316 |
D/D |
(10,395) |
1,222,329 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,438 |
1,232,724 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2022-10-15 |
4 |
D |
$5.61 |
$12,252 |
D/D |
(2,184) |
15,763 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
17,947 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2022-09-29 |
4 |
AS |
$5.24 |
$14,819 |
D/D |
(2,828) |
0 |
|
- |
|
Rowland Charles A Jr |
|
|
2022-09-19 |
4 |
B |
$5.26 |
$82,845 |
D/D |
15,750 |
191,797 |
0.01 |
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2022-09-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,905 |
|
- |
|
Rowland Charles A Jr |
|
|
2022-09-16 |
4 |
B |
$5.48 |
$183,476 |
D/D |
33,481 |
176,047 |
0.01 |
- |
|
Rowland Charles A Jr |
|
|
2022-09-15 |
4 |
B |
$5.41 |
$92,765 |
D/D |
17,147 |
142,566 |
0.01 |
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2022-09-15 |
4 |
AS |
$5.32 |
$24,525 |
D/D |
(4,610) |
2,828 |
|
- |
|
Rowland Charles A Jr |
|
|
2022-09-14 |
4 |
B |
$5.30 |
$29,652 |
D/D |
5,600 |
125,419 |
0.01 |
- |
|
Rowland Charles A Jr |
|
|
2022-09-13 |
4 |
B |
$5.20 |
$97,752 |
D/D |
18,784 |
119,819 |
0.01 |
- |
|
294 Records found
|
|
Page 5 of 12 |
|
|